Thermo Fisher Scientific Bioproduction Brochures

  1. Rapid Selection Of Robust CHO Media With A Media Screening Service 9/25/2026

    Evaluate more CHO media combinations with less internal screening burden. Examine a workflow that identifies and verifies high-performing conditions within 10 to 12 weeks.

  2. Powering Results In Downstream mAb Process Intensification And Scale-Up 9/3/2026

    See how intensified capture, polishing, inline dilution, and integrated chromatography can ease downstream bottlenecks and support scalable mAb purification while maintaining product quality.

  3. Powering Results In Harvest And Clarification Process 9/3/2026

    Higher cell densities can strain harvest operations. See how integrated centrifugation and chromatographic clarification may reduce solids, improve efficiency, and support scalable processing.

  4. Powering Results In Upstream mAb Process Scale Up 9/3/2026

    Increase mAb output without adding capacity. See how intensified seed and production strategies can shorten timelines, reduce manual handling, lower facility burden, and improve productivity.

  5. How Can You Actively Reduce Particulate Burden In Your Workflow? 8/4/2026

    Particulate control starts with practical decisions. Learn how material selection, acceptance criteria, and operator handling practices can help reduce contamination risk and support stronger quality.

  6. Nalgene Low And Ultralow Particulate Containers 8/4/2026

    Choose the right level of clean for bioproduction storage and transport, with options designed to help manage particulate, endotoxin, sterility and material requirements across critical workflows.

  7. Enabling Flexibility For T Cell Isolation And Activation Using Workflows 7/16/2026

    Modular manufacturing strategies can support scalable T-cell processing while maintaining key quality measures. Explore how workflow design choices can help balance efficiency and performance.

  8. From Process Development To QC—Optimize Your mAbs Workflow 5/29/2026

    See how integrated analytical capabilities help improve visibility across mAb workflows, enabling faster decisions, stronger process control, and reliable quality outcomes from development through QC.

  9. Leading The Way In Rapid Quantitation Of Host Cell DNA 5/29/2026

    Accurate, high-sensitivity quantitation of residual host cell DNA becomes faster and more consistent with integrated qPCR, automated prep, and broad assay coverage—helping streamline workflows.

  10. Advancing Cell Therapy With The CTS DynaCellect Magnetic Separation System 4/21/2026

    Closed, automated T cell isolation with greater than 85% efficiency and greater than 96% purity is now achievable in 70 to 100 minutes, with cGMP-ready scalability from research to clinical manufacturing.